arrow
X

Xiaozheng Kang

chinese academy of medical sciences - peking union medical college
H指数:23
被引数:2,158

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Standardized quality control in esophageal squamous cell carcinoma surgery: associations with favorable perioperative outcomes and long-term survival

食管鳞状细胞癌手术中的标准化质量控制:与良好的围手术期结局和长期生存的关系

2026-09-080
OAAI
Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2)

术前pembrolizumab (anti-PD-1抗体) 联合放化疗治疗食管鳞癌1/2期临床试验 (PALACE-2)

2025-11-280
OAAI
Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3)

新辅助卡瑞利珠单抗联合化放疗与观察等待策略 versus 新辅助化放疗后手术在局部晚期食管鳞状细胞癌中的应用:一项随机对照试验的研究方案(PALACE-3)

2025-10-150
OA
S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study
2024-10-270
OAAI
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

新辅助化疗加或不加camrelizumab治疗可切除食管鳞状细胞癌: 随机3期ESCORT-NEO/NCCES01试验

2024-07-026
OAAI
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial

食管鳞状细胞癌的新辅助放化疗和手术与根据需要进行挽救性手术的确定性放化疗的比较: 随机对照NEEDS试验的研究方案

2022-07-1320
OAAI
Pembrolizumab Combined With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Oesophageal Squamous Cell Carcinoma: Protocol for a Multicentre, Prospective, Randomized-Controlled, Phase III Clinical Study (Keystone-002)
2022-03-3136
OAAI